Fierce Pharma Mix Logo.png Fierce Pharma Mix Logo.png
Webinar

Finding Patients, Closing Treatment Gaps, and Building Better Messaging through AI and Real-World Data

ET
60 Minutes

Traditional commercial strategies focus on known patient populations— but what about patients who aren’t on the radar?

AI-powered digital phenotyping and real-world data (RWD) offer new ways to locate overlooked patient populations, identify gaps between clinical guidelines and real-world treatment patterns, and optimize market positioning and messaging. Join OM1 experts in our upcoming webinar to learn how commercial teams can leverage AI-driven real-world insights and ensure their therapies reach the patients who need them most.

Speakers

Joe Zabinski

Joseph Zabinski, PhD, MEM

VP, Head of Commercial Strategy & AI
OM1

Joseph Zabinski, PhD, MEM is VP, Head of Commercial Strategy & AI at OM1. He oversees design, implementation, and evolution of OM1's commercial strategy, including prioritization, go-to-market planning, and alignment with emergent market needs. Dr. Zabinski also serves as subject matter expert and thought leader for OM1's AI work, including applications of the PhenOM digital phenotyping platform with life science and healthcare provider partners.

OM1_HS-Kathryn.png

Kathryn Starzyk, ScM

Vice President of Real World Evidence at OM1
OM1
Kathryn Starzyk, ScM is an epidemiologist and Vice President of Research and Real-World Evidence (RWE) at OM1. She is an innovative leader in clinical research and biopharmaceutical science with 30 years of progressive experience in clinical development, real world data (RWD) optimization, RWE generation strategy, and observational research. She currently leads the Research teams at OM1, leveraging OM1’s advanced data and analytics to support research, regulatory, and commercial needs.

Register here!

Already registered? Click here to login.
Date/Time:
ET